irAE Prediction of Anti-PD-1/L1 in Lung Cancer

Immune Signature Analysis of Disease Progression in Post Immunotherapy Lung Cancer Patients

NCT05415358 ·Status: ACTIVE_NOT_RECRUITING

The Predictive Biomarkers in Patients With Locally Advanced Non-small Cell Lung Cancer

NCT06287320 ·Status: RECRUITING

Immune Checkpoint Inhibitors in Advanced Non-small Cell Lung Cancer and Discovery of New Biomarkers

NCT03658460 ·Status: COMPLETED

Consistency Analysis of PD-L1s in Advanced NSCLC Tissues and in Plasma Exosomes Before and After Radiotherapy

NCT02869685 ·Status: COMPLETED ·Phase: NA

Study of Longitudinal Plasma PD-L1 Testing With Immunotherapy in Lung Cancer

NCT06849518 ·Status: RECRUITING ·Phase: NA

Molecular Subtyping of Extensive Stage Small Cell Lung Cancer and Relevent Clinical Significance

NCT05933863 ·Status: COMPLETED

Predictive Biomarkers for Pneumonitis After Chemoradiotherapy and Immunotherapy in Patients With Non-small Cell Lung Cancer

NCT04913311 ·Status: RECRUITING

Immune-Marker Platform for Patients With Advanced Lung Cancer

NCT07150598 ·Status: NOT_YET_RECRUITING

Change in NLR and Survival Among Advanced Lung Cancer Patients Receiving ICIs With Immunomodulator

NCT04352335 ·Status: COMPLETED

Analysis of the Microenvironment of Lung Cancer and Exploration of the Mechanism of Resistance to Immunotherapy

NCT05636605 ·Status: RECRUITING

Efficacy of Neoadjuvant Immunotherapy in Patients With Lung Cancer

NCT07166003 ·Status: RECRUITING

Study of Changes of Lymphocyte Subsets in Chemotherapy Course of Patients With Non-small Cell Lung Cancer

NCT02202655 ·Status: UNKNOWN

A Study for Identification of Predictive Immune Biomarker for Atezolizumab Therapy in NSCLC Patients

NCT04312308 ·Status: COMPLETED

ctDNA as a Biomarker for Treatment in Advanced NSCLC

NCT05486988 ·Status: UNKNOWN

Foundation and Clinical About the Expression of PD-1 in Peripheral Blood T Lymphocytes

NCT05792995 ·Status: COMPLETED ·Phase: PHASE2

PD-L1 PET Imaging in Patients With the Immunotherapy for Non-small Cell Lung Cancer

NCT05533086 ·Status: UNKNOWN

Prediction of Response to Treatment With Immunotherapy + Chemotherapy in Non-Small Cell Lung Cancer

NCT04589013 ·Status: COMPLETED

Prediction Model of ICIs Combined With Chemotherapy in Advanced NSCLC

NCT05725915 ·Status: UNKNOWN

Construction of a Prognostic and Prediction Model for Perioperative Immunotherapy in NSCLC: a Multi - Omics Perspective

NCT06856798 ·Status: NOT_YET_RECRUITING

Retrospective Observational Study on Prediction of Response to PD-1 Immunotherapy in Patients with NSCLC

NCT04886401 ·Status: RECRUITING

A Perioperative Comprehensive Diagnosis and Treatment System for Lung Cancer in the Era of Neoadjuvant Immunotherapy

NCT07119190 ·Status: NOT_YET_RECRUITING

Monitoring the Changes of Tumor-related Biomarkers Before and After Pulmonary Nodule Biopsy.

NCT03397355 ·Status: UNKNOWN

Association Between Microbiome and the Efficacy and Safety of PD-1/PD-L1 Blockade in Resectable NSCLC

NCT06613308 ·Status: NOT_YET_RECRUITING

Targeted Anti-CEA CAR-T Immunotherapy for Advanced Lung Cancer

NCT06992583 ·Status: RECRUITING ·Phase: PHASE1

A Clinical Study on the Analysis of Risk Factors for the Occurrence of PD-1/PD-L1 Inhibitor-associated Liver Injury in Lung Cancer Patients

NCT06402981 ·Status: RECRUITING